Journal of General Virology, Vol 80, 1231-1240, Copyright © 1999 by Society for General Microbiology

ARTICLES

A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey

K Shinohara, K Sakai, S Ando, Y Ami, N Yoshino, E Takahasi, K Someya, Y Suzaki, T Nakasone, Y Sasaki, M Kaizu, Y Lu and M Honda
Division of Biosafety Control and Research, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640, Japan

A highly pathogenic simian/human immunodeficiency virus (SHIV), designated C2/1, was obtained by serum passages in cynomolgus monkeys of p-SHIV, an SHIV strain that contains the env gene of pathogenic human immunodeficiency virus type 1 89.6. CD4+ lymphocyte depletion was induced within 1 week of the SHIV-C2/1 infection in peripheral blood as well as in various lymphoid organs in all the animals tested, with symptoms of diarrhoea and no increase in body weight, followed by intense viraemia. Serum antibody against Env protein was detected from 4 weeks after the virus infection, while the anti-Gag antibody response was absent in the SHIV-C2/1-infected animals. In contrast, both anti-Gag and anti-Env antibody responses were present in animals infected with p-SHIV or the non-pathogenic SHIV-MN. Sequencing of the env gene of isolates of SHIV-C strains showed conserved amino acid changes in the Env C2 and V3 regions that included changes to negatively charged amino acids, in the cytoplasmic region of gp41 that included a 42 amino acid deletion, and in the Nef protein. The pathogenic SHIV-C2/1--monkey model suggests that virus-specific pathogenicity in SHIV infection may be associated with the absence of anti-Gag antibody responses in animals and may be caused by genetic changes during serum passage in vivo.

This article has been cited by other articles:

				Y. Fukazawa, A. Miyake, K. Ibuki, K. Inaba, N. Saito, M. Motohara, R. Horiuchi, A. Himeno, K. Matsuda, M. Matsuyama, et al. Small Intestine CD4+ T Cells Are Profoundly Depleted during Acute Simian-Human Immunodeficiency Virus Infection, Regardless of Viral Pathogenicity J. Virol., June 15, 2008; 82(12): 6039 - 6044. [Abstract] [Full Text] [PDF]

				S. Watanabe, K. Terashima, S. Ohta, S. Horibata, M. Yajima, Y. Shiozawa, M. Z. Dewan, Z. Yu, M. Ito, T. Morio, et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2R{gamma}null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses Blood, January 1, 2007; 109(1): 212 - 218. [Abstract] [Full Text] [PDF]

				A. Miyake, K. Ibuki, Y. Enose, H. Suzuki, R. Horiuchi, M. Motohara, N. Saito, T. Nakasone, M. Honda, T. Watanabe, et al. Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1311 - 1320. [Abstract] [Full Text] [PDF]

				K. Someya, Y. Ami, T. Nakasone, Y. Izumi, K. Matsuo, S. Horibata, K.-Q. Xin, H. Yamamoto, K. Okuda, N. Yamamoto, et al. Induction of Positive Cellular and Humoral Immune Responses by a Prime-Boost Vaccine Encoded with Simian Immunodeficiency Virus gag/pol J. Immunol., February 1, 2006; 176(3): 1784 - 1795. [Abstract] [Full Text] [PDF]

				Y. Ami, Y. Izumi, K. Matsuo, K. Someya, M. Kanekiyo, S. Horibata, N. Yoshino, K. Sakai, K. Shinohara, S. Matsumoto, et al. Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guerin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity J. Virol., October 15, 2005; 79(20): 12871 - 12879. [Abstract] [Full Text] [PDF]

				K. Someya, D. Cecilia, Y. Ami, T. Nakasone, K. Matsuo, S. Burda, H. Yamamoto, N. Yoshino, M. Kaizu, S. Ando, et al. Vaccination of Rhesus Macaques with Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Env V3 Elicits Neutralizing Antibody-Mediated Protection against Simian-Human Immunodeficiency Virus with a Homologous but Not a Heterologous V3 Motif J. Virol., February 1, 2005; 79(3): 1452 - 1462. [Abstract] [Full Text] [PDF]

				K. Yamakami, M. Honda, M. Takei, Y. Ami, N. Kitamura, S. Nishinarita, S. Sawada, and T. Horie Early Bone Marrow Hematopoietic Defect in Simian/Human Immunodeficiency Virus C2/1-Infected Macaques and Relevance to Advance of Disease J. Virol., October 15, 2004; 78(20): 10906 - 10910. [Abstract] [Full Text] [PDF]

				K. Someya, K.-Q. Xin, K. Matsuo, K. Okuda, N. Yamamoto, and M. Honda A Consecutive Priming-Boosting Vaccination of Mice with Simian Immunodeficiency Virus (SIV) gag/pol DNA and Recombinant Vaccinia Virus Strain DIs Elicits Effective Anti-SIV Immunity J. Virol., September 15, 2004; 78(18): 9842 - 9853. [Abstract] [Full Text] [PDF]

				Y. Izumi, Y. Ami, K. Matsuo, K. Someya, T. Sata, N. Yamamoto, and M. Honda Intravenous Inoculation of Replication-Deficient Recombinant Vaccinia Virus DIs Expressing Simian Immunodeficiency Virus Gag Controls Highly Pathogenic Simian-Human Immunodeficiency Virus in Monkeys J. Virol., December 15, 2003; 77(24): 13248 - 13256. [Abstract] [Full Text] [PDF]

				R. K. Plemper, A. L. Hammond, D. Gerlier, A. K. Fielding, and R. Cattaneo Strength of Envelope Protein Interaction Modulates Cytopathicity of Measles Virus J. Virol., April 16, 2002; 76(10): 5051 - 5061. [Abstract] [Full Text] [PDF]

				J. B. Johnston and C. Power Feline Immunodeficiency Virus Xenoinfection: the Role of Chemokine Receptors and Envelope Diversity J. Virol., March 19, 2002; 76(8): 3626 - 3636. [Abstract] [Full Text] [PDF]